30 Apr 2017 | 2:02 PM
 

Divi`s Laboratories Ltd. Share Price Live (BSE)
0

BSE Code: 532488 | NSE Symbol: DIVISLAB
627.96
-3.00
(-0.47 %)
28 Apr 2017 | 04:01 PM
Change company
  • Open (Rs)
    631.00
  • Prev. close (Rs.)
    630.96
  • High (Rs.)
    633.96
  • Low (Rs.)
    625.25
  • 52W H (Rs.)
    1,380.00
  • 52W L (Rs.)
    607.00
  • Volume (Rs.)
    106663
  • MCap (Rs in Cr.)
    16,670.13
631.95
-1.15
(-0.18 %)
  • Open (Rs)
    634.55
  • High (Rs)
    636.70
  • Low (Rs)
    629.30
  • Prev. close(Rs)
    633.10
  • Contracts Tra.
    10,72,800
  • Turnover (Cr.)
    68
  • Open Interest
    93,64,200
  • Open Int. chg
    1,74,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
64.15
Operating Margin (%)
37.40
Gross Profit Margin (%)
33.04
Net Profit Margin (%)
27.33
Total Debt/Equity
0.01
Dividend payout Ratio (Net Profit)
37.52
Earning Retention Ratio
62.48

News

24 Apr 2017 - 11:20:00-Drug firm Divi's Laboratories said that the US health regulator has issued a warning letter to ...
24 Apr 2017 - 09:51:00-Shares of Divi's Laboratories dipped nearly 4 per cent hitting 52-week low in early trade on the...
22 Mar 2017 - 11:51:00-Shares of Divi's Laboratories continued losing streak of the second day and tanked over 3 per ce...
21 Mar 2017 - 12:07:00-Drug firm Divi's Laboratories Ltd on Tuesday said the US health regulator has issued an import a...

Announcements

22-Apr-2017
Divi`s Lab - Updates
08-Apr-2017
Divi`s Lab - Updates
07-Apr-2017
Divi`s Lab - Compliance Certificate For Half Year Ended 31St March 2017
07-Apr-2017
Divi`s Lab - Compliance Certificate For The Period Ended 31St March 2017
07-Apr-2017
Divi`s Lab - Shareholding for the Period Ended March 31 2017

Religare Research

28 Apr 2017 | 05:39 PM
The Nifty index gained 2% led by good quarterly earnings and positive global cues. Even though the o...
28 Apr 2017 | 05:35 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
28 Apr 2017 | 03:38 PM
Akshaya Tritiya is a very popular festival that the Hindus celebrate every year. It is considered as...
28 Apr 2017 | 01:31 PM
Nifty futures has rolled around 66% vs 68%, with respect to last month, and the open interest for th...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
24,33,441 575.29 82.56 0.46
24,33,441 575.29 30.43 0.46
24,33,441 575.29 82.56 0.46
24,33,441 575.29 21.95 0.70
24,33,441 575.29 85.32 0.47

Shareholding Pattern

       
Promotors52.07%
Mutual Funds/UTI13.75%
FI/Banks0.45%
Insurance0.45%
FII17.22%
Government0.00%
Others6.72%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,604.85(0.45)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,500.45(-2.25)
3317
 Piramal Enterprises Ltd.
2,490.00(0.74)
3356
 Alkem Laboratories Ltd.
1,964.90(2.55)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Divi`s Laboratories Ltd.-3.95-73.40-647.35
NIFTY(S&P CNX)203.25671.30666.05
BSE SENSEX508.882,068.841,976.89
BSE 500477.041,205.501,125.87

Corporate Details

Key Personal
Kiran S Divi
President & Director
Madhusudana Rao Divi
Director - Projects
Murali K Divi
Chairman & Managing Director
Key Address
Registered Office
1-72/23(P)/DIVIS/303 Divi Towers Cyber Hills Gachibowli,Hyderabad,Telangana

Tel:040-23786300, Fax:040-23786460

mail@divislaboratories.com
http://www.divislaboratories.com
Registrar Office
In House

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Divi`s Laboratories Ltd. that will help you decide whether to buy, sell or hold Divi`s Laboratories Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Divi`s Laboratories Ltd.